| Product Code: ETC13155511 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Preimplantation Genetic Screening Technology Market was valued at USD 0.8 Billion in 2024 and is expected to reach USD 1.2 Billion by 2031, growing at a compound annual growth rate of 5.70% during the forecast period (2025-2031).
The Global Preimplantation Genetic Screening (PGS) Technology Market is witnessing significant growth driven by increasing awareness about genetic disorders, rising demand for assisted reproductive technologies, and advancements in genetic screening techniques. PGS helps identify chromosomal abnormalities in embryos before implantation during in vitro fertilization (IVF) procedures, thereby reducing the risk of genetic diseases and improving the chances of successful pregnancies. Key market players are focusing on developing innovative PGS technologies with higher accuracy and efficiency, while collaborations and partnerships are also contributing to market expansion. Geographically, North America and Europe dominate the market due to higher adoption rates of IVF procedures and favorable regulatory frameworks. However, the Asia-Pacific region is expected to exhibit rapid growth due to improving healthcare infrastructure and increasing disposable incomes.
The Global Preimplantation Genetic Screening (PGS) Technology Market is experiencing significant growth due to the increasing demand for advanced genetic screening techniques in assisted reproductive technology. Key trends in the market include the adoption of next-generation sequencing technology for more accurate and comprehensive genetic screening, the rising prevalence of genetic disorders driving the need for PGS, and the growing awareness among consumers about the benefits of PGS in improving IVF success rates. Opportunities in the market lie in the development of innovative PGS technologies to enhance accuracy and efficiency, expanding applications beyond genetic disorders to include screening for chromosomal abnormalities and single gene defects, and the potential for market expansion in emerging economies with growing demand for fertility treatments. Collaboration between technology providers and fertility clinics to offer integrated solutions and personalized services also presents growth opportunities in the Global PGS Technology Market.
The Global Preimplantation Genetic Screening (PGS) Technology Market faces several challenges, including ethical concerns regarding the selection of embryos based on genetic traits, high costs associated with the procedure, and limited availability of skilled professionals to perform the tests. Additionally, there are regulatory challenges in different countries regarding the use of PGS technology, with some regions having restrictions or bans on certain types of genetic screening. The accuracy and reliability of PGS results are also areas of concern, as false positives or negatives can impact decision-making for couples undergoing fertility treatments. Overall, addressing these challenges will be crucial for the widespread adoption and success of PGS technology in the global market.
The Global Preimplantation Genetic Screening (PGS) Technology Market is primarily driven by increasing awareness about genetic disorders, rising incidences of chromosomal abnormalities in embryos, and advancements in genetic testing techniques. Growing demand for successful pregnancies, coupled with the rising trend of delayed parenthood, is also fueling the market growth. Additionally, the expanding applications of PGS in detecting genetic abnormalities and minimizing the risk of inherited diseases in offspring are boosting market demand. Technological advancements leading to more accurate and cost-effective PGS procedures, along with the increasing availability of genetic counseling services, are further driving the market. Furthermore, supportive government initiatives and investments in research and development activities related to genetic screening technologies are contributing to the market`s expansion.
Government policies related to the Global Preimplantation Genetic Screening Technology Market vary by country, with some regulating the use of this technology more strictly than others. In the United States, the Food and Drug Administration (FDA) oversees the regulation of preimplantation genetic screening tests as medical devices, ensuring their safety and effectiveness. In the European Union, the use of preimplantation genetic screening is governed by the European Society of Human Reproduction and Embryology (ESHRE) guidelines, which provide recommendations on the ethical and legal aspects of using this technology. Overall, government policies aim to strike a balance between promoting technological advancements in genetic screening while also safeguarding the well-being of patients and ensuring ethical considerations are taken into account.
The Global Preimplantation Genetic Screening (PGS) Technology Market is poised for significant growth in the coming years due to the rising demand for advanced genetic screening techniques in assisted reproductive technology (ART) procedures. Factors such as increasing infertility rates, growing awareness about genetic disorders, and advancements in genomic technologies are driving the market expansion. Additionally, the trend towards delayed parenthood and the higher prevalence of genetic abnormalities in embryos among older women are further fueling the adoption of PGS technology. The market is expected to witness a surge in research and development activities to enhance the accuracy and efficiency of PGS technology, as well as strategic collaborations and partnerships among key players to strengthen their market presence. Overall, the Global PGS Technology Market is anticipated to experience robust growth in the foreseeable future.
The Preimplantation Genetic Screening (PGS) technology market varies across regions. In Asia, the market is witnessing significant growth due to the rising awareness about genetic screening and increasing demand for advanced fertility treatments. North America is a mature market with a high adoption rate of PGS technology, driven by the presence of well-established healthcare infrastructure and increasing focus on personalized medicine. In Europe, the market is characterized by stringent regulations governing genetic testing, leading to a slower adoption rate compared to other regions. The Middle East and Africa region is experiencing a gradual uptake of PGS technology, attributed to improving healthcare facilities and rising infertility rates. Latin America is emerging as a promising market for PGS technology, driven by increasing healthcare expenditure and growing awareness about genetic screening among the population.
Global Preimplantation Genetic Screening (PGS) Technology Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Preimplantation Genetic Screening (PGS) Technology Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Global Preimplantation Genetic Screening (PGS) Technology Market - Industry Life Cycle |
3.4 Global Preimplantation Genetic Screening (PGS) Technology Market - Porter's Five Forces |
3.5 Global Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.7 Global Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Global Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Product and Services, 2021 & 2031F |
3.9 Global Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Global Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.11 Global Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Preimplantation Genetic Screening (PGS) Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Preimplantation Genetic Screening (PGS) Technology Market Trends |
6 Global Preimplantation Genetic Screening (PGS) Technology Market, 2021 - 2031 |
6.1 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Preimplantation Genetic Screening, 2021 - 2031 |
6.1.3 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Preimplantation Genetic Diagnosis, 2021 - 2031 |
6.2 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031 |
6.2.3 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Polymerase Chain Reaction, 2021 - 2031 |
6.2.4 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Fluorescence in Situ Hybridization, 2021 - 2031 |
6.2.5 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Comparative Genomic Hybridization, 2021 - 2031 |
6.2.6 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Single-Nucleotide Polymorphism, 2021 - 2031 |
6.3 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Reagents and Consumables, 2021 - 2031 |
6.3.3 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.3.4 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Software and Services, 2021 - 2031 |
6.4 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Maternity Centers, 2021 - 2031 |
6.4.3 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Fertility Clinics, 2021 - 2031 |
6.4.4 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Hospitals, Diagnostic Labs, 2021 - 2031 |
6.4.5 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Service Providers, 2021 - 2031 |
6.4.6 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Research Laboratories, 2021 - 2031 |
6.4.7 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Academic Institutes, 2021 - 2031 |
6.5 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Test Type, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Chromosomal Abnormalities, 2021 - 2031 |
6.5.3 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By X-linked Diseases, Embryo Testing, 2021 - 2031 |
6.5.4 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Aneuploidy Screening, 2021 - 2031 |
6.5.5 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By HLA Typing, 2021 - 2031 |
6.5.6 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Other, 2021 - 2031 |
6.6 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Embryo HLA Typing for Stem Cell Therapy, 2021 - 2031 |
6.6.3 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By IVF Prognosis, 2021 - 2031 |
6.6.4 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Late Onset Genetic Disorders, 2021 - 2031 |
6.6.5 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Inherited Genetic Disease, 2021 - 2031 |
6.6.6 Global Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Preimplantation Genetic Screening (PGS) Technology Market, Overview & Analysis |
7.1 North America Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, 2021 - 2031 |
7.2 North America Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
7.4 North America Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5 North America Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
7.6 North America Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7 North America Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.8 North America Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Preimplantation Genetic Screening (PGS) Technology Market, Overview & Analysis |
8.1 Latin America (LATAM) Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
8.4 Latin America (LATAM) Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Technology, 2021 - 2031 |
8.5 Latin America (LATAM) Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
8.6 Latin America (LATAM) Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
8.7 Latin America (LATAM) Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Test Type, 2021 - 2031 |
8.8 Latin America (LATAM) Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Preimplantation Genetic Screening (PGS) Technology Market, Overview & Analysis |
9.1 Asia Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
9.4 Asia Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Technology, 2021 - 2031 |
9.5 Asia Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
9.6 Asia Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
9.7 Asia Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Test Type, 2021 - 2031 |
9.8 Asia Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Preimplantation Genetic Screening (PGS) Technology Market, Overview & Analysis |
10.1 Africa Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
10.4 Africa Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Technology, 2021 - 2031 |
10.5 Africa Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
10.6 Africa Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
10.7 Africa Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Test Type, 2021 - 2031 |
10.8 Africa Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Preimplantation Genetic Screening (PGS) Technology Market, Overview & Analysis |
11.1 Europe Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
11.4 Europe Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Technology, 2021 - 2031 |
11.5 Europe Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
11.6 Europe Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
11.7 Europe Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Test Type, 2021 - 2031 |
11.8 Europe Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Preimplantation Genetic Screening (PGS) Technology Market, Overview & Analysis |
12.1 Middle East Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Procedure Type, 2021 - 2031 |
12.4 Middle East Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Technology, 2021 - 2031 |
12.5 Middle East Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Product and Services, 2021 - 2031 |
12.6 Middle East Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
12.7 Middle East Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Test Type, 2021 - 2031 |
12.8 Middle East Preimplantation Genetic Screening (PGS) Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Preimplantation Genetic Screening (PGS) Technology Market Key Performance Indicators |
14 Global Preimplantation Genetic Screening (PGS) Technology Market - Export/Import By Countries Assessment |
15 Global Preimplantation Genetic Screening (PGS) Technology Market - Opportunity Assessment |
15.1 Global Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
15.3 Global Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Technology, 2021 & 2031F |
15.4 Global Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Product and Services, 2021 & 2031F |
15.5 Global Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
15.6 Global Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Test Type, 2021 & 2031F |
15.7 Global Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Preimplantation Genetic Screening (PGS) Technology Market - Competitive Landscape |
16.1 Global Preimplantation Genetic Screening (PGS) Technology Market Revenue Share, By Companies, 2024 |
16.2 Global Preimplantation Genetic Screening (PGS) Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here